DAO | D-amino-acid oxidase | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FMO3 | Flavin containing monooxygenase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP2B6 | Cytochrome P450, family 2, subfamily B, polypeptide 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MAT1A | Methionine adenosyltransferase I, alpha | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ALB | Albumin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
GC | Group-specific component (vitamin D binding protein) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ACOT12 | Acyl-CoA thioesterase 12 | Enzymes Transporters
| | | | | Tissue enriched |
ITIH4 | Inter-alpha-trypsin inhibitor heavy chain family, member 4 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
AMBP | Alpha-1-microglobulin/bikunin precursor | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ASGR1 | Asialoglycoprotein receptor 1 | | | | | | Tissue enriched |
UGT2B4 | UDP glucuronosyltransferase 2 family, polypeptide B4 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ASGR2 | Asialoglycoprotein receptor 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
APOM | Apolipoprotein M | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC27A5 | Solute carrier family 27 (fatty acid transporter), member 5 | Enzymes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
BAAT | Bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DPYS | Dihydropyrimidinase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
GLYATL1 | Glycine-N-acyltransferase-like 1 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
HSD17B6 | Hydroxysteroid (17-beta) dehydrogenase 6 | Enzymes
| | | | | Tissue enriched |
TF | Transferrin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACMSD | Aminocarboxymuconate semialdehyde decarboxylase | Enzymes
| | | | | Group enriched |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PON3 | Paraoxonase 3 | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA1 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins
| | | | | Tissue enriched |
HAL | Histidine ammonia-lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
HRSP12 | Heat-responsive protein 12 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes
| | | | | Group enriched |
GCKR | Glucokinase (hexokinase 4) regulator | | | | | | Group enriched |
HGFAC | HGF activator | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LRG1 | Leucine-rich alpha-2-glycoprotein 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PROC | Protein C (inactivator of coagulation factors Va and VIIIa) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TFR2 | Transferrin receptor 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
RBP4 | Retinol binding protein 4, plasma | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |